ZBIO

Zenas BioPharma Inc. Common Stock

HealthcareBiotechnologyUnited StatesNASDAQ

$20.96

+0.96%today

MKT CAP

$1.3B

-1.6% · 1Y

Full Financials

Trailing P/E-

Forward P/E-3.8x

EV/EBITDA-

Price/Sales-

Dividend Yield-

Revenue Growth YoY-

Earnings Growth YoY-

Revenue Growth QoQ-

5y Revenue CAGR-

5y Earnings CAGR-

Gross Margin-

Operating Margin-

Net Margin-

ROE-

Debt / Equity-

Free Cash Flow-

Insider Ownership24.5%

Institutional Ownership75.2%

Short % of Float24.58%

Days to Cover10.0d

1 Week+15.3%

1 Month-

3 Months-

6 Months-

YTD-

1 Year-

3 Years-

5 Years-

vs 50-day SMA-

vs 200-day SMA-

vs 52w High-

vs 52w Low-

Peers

Ticker	Cap	Score	P/E	Fwd P/E	EV/EBITDA	ROE	Gross	D/E	Div
PTGX Protagonist Therapeutics Inc. Common Stock	$6.6B	5	-	-	-	-	-	-	0.00%
CELC Celcuity Inc. Common Stock	$6.7B	5	-	-	-	-	-	-	0.00%
ACLX Arcellx Inc. Common Stock	$6.7B	5	-	-	-	-	-	-	-
KYMR Kymera Therapeutics Inc. Common Stock	$7.0B	-	-	-	-	-27.1%	0%	5.23	0.00%
TECH Bio-Techne Corp Common Stock	$7.1B	36	72.7	24.4	-	-	-	-	63.00%
HALO Halozyme Therapeutics Inc. Common Stock	$7.9B	73	25.5	6.6	-	-	-	-	0.00%